Immunopathology of viral encephalitis - Avindra Nath, MD

Viral Infections & Inflammation Workshop 2023

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023

High Levels of Il-1, Tnf- and Mip-1 One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients - Jacobo Alonso-Domínguez

Viral Infections & Inflammation Workshop 2023

Viruses, Immune Dysfunction, and ME/CFS - Maureen Hanson, PhD

Viral Infections & Inflammation Workshop 2023

Underlying Mechanisms of Long COVID - Michael Peluso, MD

Viral Infections & Inflammation Workshop 2023

Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV - Steven Grinspoon, MD

Viral Infections & Inflammation Workshop 2023

A New Player in the Management of Liver Disease in Sub-Saharan Africa - The Tanzania IR Experience - Erick Mbuguje, MD.pdf

Conference on Liver Disease in Africa (COLDA) 2023

A Global Action Agenda for Turning the Tide on Fatty Liver Disease - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Assessment of Hepatocellular Carcinoma Differences in Urban and Rural Africa Through Satellite Imaging Analysis - Jose Debes.pdf

Conference on Liver Disease in Africa (COLDA) 2023

African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Barriers to Implementation_Access to Care - Danjuma K. Adda, MPH, FIMS, Dip-IMS.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Bilharzia and Viral Hepatitis - Imam Waked, MD, FRCP, FAASLD.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Compared to the Wild-type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wntβ--catenin Pathway in Vitro .pdf

Conference on Liver Disease in Africa (COLDA) 2023

Effectiveness of Tenofovir Prophylaxis for the Prevention of Mother-To-Child- Transmission of Hepatitis B Virus in Burkina Faso - Serge Ouoba.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Establishing the Hepatitis B and C Prevention and Management Program - Malawi’s Experience - Wongani Mzumara.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Fatty Liver Disease and Its Correlates Among People Living with HIV Attending Care and Treatment Clinic at Temeke Regional Referral Hospital, Dar es Salaa.pdf

Conference on Liver Disease in Africa (COLDA) 2023

HBeAg and HBV DNA in the Hepatitis B in Africa Collaborative Network (HEPSANET) - Alexander Stockdale.pdf

Conference on Liver Disease in Africa (COLDA) 2023

HCV_Effect of Reinfection on Elimination - Importance of Self Testing - Janvier Serumondo, MD, MPH, MTM.pptx

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B (HBV) Testing and Treatment Policy Assessment in Six African Countries - Examples to Inform HBV Program Scale-Up - Lindsey Hiebert.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis E Virus Detected in Wastewater Samples in South Africa - Bronwyn Roberts.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B Virus Genotypes - Anna Kramvis, BSc Hons, PhD.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Introducing Sofosbuvir_Velpatasvir+Ribavirin as a Generic Retreatment - Janvier Serumondo.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Implementation of HBV Screening in Kilifi, Kenya - Real World Insights to Inform Clinical Service Development and Translational Studies - Louise Downs.pdf

Conference on Liver Disease in Africa (COLDA) 2023

Long-term Outcomes of a Population-Based Cohort of Chronic Hepatitis B (CHB) Patients in West Africa - Gibril Ndow.pdf

Conference on Liver Disease in Africa (COLDA) 2023